London, 03 October 2022, Consilium Strategic Communications (Consilium), a global leader in strategic healthcare communications and investor relations, is proud to co-sponsor the 7th annual Future of Healthcare Investment Forum, taking place at the London Stock Exchange on October 4th.
The event, which brings together the most innovative companies in healthcare and technology for blue chip investors, is taking place at the London Stock Exchange in partnership with the BioIndustry Association, JP Morgan, Numis and MedCity. Leading public and private healthcare companies, members of the investor community and experts will meet to discuss what is needed to fund and grow innovative healthcare companies in a fast-changing commercial environment.
The forum will feature keynote speakers including Stephen Lightfoot, Chair of the UK Medicines & Healthcare products Regulatory Agency (MHRA) and Sir Jonathan Symonds, non-executive Chair of GlaxoSmithKline.
Two panel sessions will examine the ways in which technology is changing our approach to drug discovery and development and the delivery of healthcare respectively, with panellists including representatives from Oxford Nanopore plc, Healx, C4X Discovery and CMR Surgical. Amber Fennell, Partner and Co-Founder of Consilium, will chair the first panel: Companies applying data and technology to drug discovery and development and technology-enabled healthcare.
Mary-Jane Elliott, Managing Partner at Consilium Strategic Communications, said: “The Future of Healthcare Investor Forum has emerged as a premier event for investors interested in dynamic companies at the nexus of healthcare and technology and their potential to power economic growth for the UK and beyond. We’re thrilled to be able to continue to support this event, which goes from strength to strength every year.”
The full agenda and registration instructions for the event can be found here.
